Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Chrisann Kyi"'
Autor:
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTIeramilimab, a humanized anti-LAG-3 monoclonal antibody, was well tolerated in combination with the anti-PD-1 antibody spartalizumab in a phase 1 study. This phase 2 study aimed to further investigate the efficacy and safety of combination tr
Externí odkaz:
https://doaj.org/article/fba32163599d40e7abcb0008f2589a1a
Autor:
Tian Zhang, Filippo de Braud, Taito Esaki, Wallace Akerley, Chrisann Kyi, Richard D Carvajal, Daniel Gusenleitner, Patrick Schöffski, Miguel Martin, David S Hong, Amy Prawira, Jürgen Krauß, Nidhi Patel, Rina Hui, Andrew Weickhardt, Niladri Roy Chowdhury, Daniel S W Tan, María Ochoa-de-Olza, John Sarantopoulos, Ross A Soo, Michela Maur, Barbara Deschler-Baier, Allen Lau, Tanay S Samant, Tyler Longmire, Catherine A Sabatos-Peyton, Radha Ramesh, Tiancen Hu, Ana Carion, Padmaja Yerramilli-Rao, Vasileios Askoxylakis, Eunice L Kwak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/c14ae2c468844f0d8af45992b1b6b8f2
Autor:
Kathryn M. Miller, Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu-Rustum, Carol Aghajanian, Vance Broach, Lora H. Ellenson, Pier Selenica, Elizabeth L. Jewell, Chrisann Kyi, Yuliya Lakhman, Jennifer J. Mueller, Roisin E. O'Cearbhaill, Kay J. Park, Yukio Sonoda, Dmitriy Zamarin, Britta Weigelt, Mario M. Leitao, Jr, Claire F. Friedman
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100831- (2021)
Objective: Since the approval of pembrolizumab for advanced or recurrent PD-L1 positive (CPS > 1%) cervical cancer, the clinical characteristics associated with response have remained undefined. We sought to characterize the clinicopathologic feature
Externí odkaz:
https://doaj.org/article/f9fa330185344c4388e2ef3b496eba95
Autor:
Chrisann Kyi, Claire F. Friedman, Jennifer J. Mueller, Ryma Benayed, Marc Ladanyi, Maria Arcila, Soo Ryum Yang, Martee L. Hensley, Sarah Chiang
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100852- (2021)
Inflammatory myofibroblastic tumor (IMT) of the uterus is a rare but aggressive malignancy that is often misdiagnosed. Approximately 50% of uterine IMTs (UMT) harbor rearrangements involving the ALK gene on chromosome 2p23 with subsequent overexpress
Externí odkaz:
https://doaj.org/article/93a2b4ec54e54a238aebf18abee3b9e4
Autor:
Chrisann Kyi, Alexia Iasonos, Carol Aghajanian, Paul Sabbatini, Ekaterina Doubrovina, Sara Kravetz, David Spriggs, Richard J O'Reilly, Roisin E O’Cearbhaill
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/f7056119a4df4d95a6126042111a2959
Autor:
Bin Li, Jun Li, Tian Chen, Uwe M Martens, Lazar Vujanovic, Rom Leidner, Robert L Ferris, William Sharfman, Chrisann Kyi, Suzanne L Topalian, Janis M Taube, Christine H Chung, William C Spanos, Anthony Gonçalves, Lot A Devriese, Helene Gauthier, Simon I Chiosea, Julie E Stein, Adam Barrows
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Head and neck squamous cell carcinomas (HNSCCs) are common malignancies caused by carcinogens, including tobacco and alcohol, or infection with human papillomavirus (HPV). Immune checkpoint inhibitors targeting the programmed cell death 1
Externí odkaz:
https://doaj.org/article/5b3e3b1bc7294331bf25fd5f151678dd
Autor:
Philip Friedlander, Karl Wassmann, Alan M. Christenfeld, David Fisher, Chrisann Kyi, John M. Kirkwood, Nina Bhardwaj, William K. Oh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-9 (2017)
Abstract Background Tremelimumab is an antibody that blocks CTLA-4 and demonstrates clinical efficacy in a subset of advanced melanoma patients. An unmet clinical need exists for blood-based response-predictive gene signatures to facilitate clinicall
Externí odkaz:
https://doaj.org/article/e871d5f254414ab0bdf89b06056cc7a9
Autor:
Sung Soo Mun, Leila Peraro, Jeremy Meyerberg, Tatyana Korontsvit, Manish Malviya, Thomas Gardner, Chrisann Kyi, Roisin E. O’Cearbhaill, Cheng Liu, Tao Dao, David A. Scheinberg
Epithelial ovarian cancer is the most lethal of gynecological cancers. The therapeutic efficacy of chimeric antigen receptor (CAR) T cell directed against single antigens is limited by the heterogeneous target antigen expression in epithelial ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b05af0d42de924605e84757f88b01c
https://doi.org/10.21203/rs.3.rs-2887299/v1
https://doi.org/10.21203/rs.3.rs-2887299/v1
Autor:
Jedd D. Wolchok, Jianda D. Yuan, Sacha Gnjatic, James P. Allison, Zhenyu Mu, Chrisann Kyi, Daniel Hirschhorn-Cymerman, Caillian Liu, Takemasa Tsuji, Shigehisa Kitano
PDF file - 144K, Supplemental Figure 1 NY-ESO-1 antigen-specific CD4+ T cell lines were CD8 negative.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405433bff90f9befa4664b8932e3a2f8
https://doi.org/10.1158/2326-6066.22536949.v1
https://doi.org/10.1158/2326-6066.22536949.v1
Autor:
Jedd D. Wolchok, Jianda D. Yuan, Sacha Gnjatic, James P. Allison, Zhenyu Mu, Chrisann Kyi, Daniel Hirschhorn-Cymerman, Caillian Liu, Takemasa Tsuji, Shigehisa Kitano
PDF file - 106K, Supplemental Table 1 Summary of NY-ESO-1 Immune responses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419a6224fef0ce11a4a45e40b419b7c9
https://doi.org/10.1158/2326-6066.22536946.v1
https://doi.org/10.1158/2326-6066.22536946.v1